OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel High-Drug-Loaded Amorphous Dispersion Tablets of Posaconazole; In Vivo and In Vitro Assessment
Deanna M. Mudie, Aaron M. Stewart, Nishant Biswas, et al.
Molecular Pharmaceutics (2020) Vol. 17, Iss. 12, pp. 4463-4472
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Recent Advances in Amorphous Solid Dispersions: Preformulation, Formulation Strategies, Technological Advancements and Characterization
Srushti Tambe, Divya Jain, Saikishore Meruva, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2203-2203
Open Access | Times Cited: 75

Impact of Gastric pH Variations on the Release of Amorphous Solid Dispersion Formulations Containing a Weakly Basic Drug and Enteric Polymers
Hanh Thuy Nguyen, Tu Van Duong, Lynne S. Taylor
Molecular Pharmaceutics (2023) Vol. 20, Iss. 3, pp. 1681-1695
Open Access | Times Cited: 32

Amorphous Solid Dispersions (ASDs): The Influence of Material Properties, Manufacturing Processes and Analytical Technologies in Drug Product Development
Raman Iyer, Vesna Petrovska Jovanovska, Katja Berginc, et al.
Pharmaceutics (2021) Vol. 13, Iss. 10, pp. 1682-1682
Open Access | Times Cited: 53

Impact of Crystal Nuclei on Dissolution of Amorphous Drugs
Xin Yao, Lian Yu, Geoff G. Z. Zhang
Molecular Pharmaceutics (2023) Vol. 20, Iss. 3, pp. 1796-1805
Closed Access | Times Cited: 16

Surface nanocoating of high drug-loading spray-dried amorphous solid dispersions by atomic layer coating: Excellent physical stability under accelerated storage conditions for two years
Tu Van Duong, Hanh Thuy Nguyen, Fei Wang, et al.
International Journal of Pharmaceutics (2022) Vol. 620, pp. 121747-121747
Closed Access | Times Cited: 19

Strategies to improve the stability of amorphous solid dispersions in view of the hot melt extrusion (HME) method
Khater AL-Japairai, Samah Hamed Almurisi, Syed Mahmood, et al.
International Journal of Pharmaceutics (2023) Vol. 647, pp. 123536-123536
Closed Access | Times Cited: 11

Advances in formulation strategies and stability considerations of amorphous solid dispersions
Dhanashri Pendam, Pranoti Tomake, Shubham Debaje, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106922-106922
Closed Access

Chemistry and Ionization of HPMCAS Influences the Dissolution and Solution-Mediated Crystallization of Posaconazole Amorphous Solid Dispersions
Dishan D. Shah, Lynne S. Taylor
Journal of Pharmaceutical Sciences (2024)
Closed Access | Times Cited: 3

Structural Modifications of Polyethylenimine to Control Drug Loading and Release Characteristics of Amorphous Solid Dispersions
Kristen N. Kelsall, Leila M. Foroughi, Derek S. Frank, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 3, pp. 1779-1787
Closed Access | Times Cited: 8

Efficient development of sorafenib tablets with improved oral bioavailability enabled by coprecipitated amorphous solid dispersion
Sichen Song, Chenguang Wang, Shan Wang, et al.
International Journal of Pharmaceutics (2021) Vol. 610, pp. 121216-121216
Closed Access | Times Cited: 19

Optimizing Solvent Selection and Processing Conditions to Generate High Bulk-Density, Co-Precipitated Amorphous Dispersions of Posaconazole
Derek S. Frank, Luke Schenck, Athanas Koynov, et al.
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2017-2017
Open Access | Times Cited: 17

Inhaled JAK Inhibitor GDC-0214 Nanoaggregate Powder Exhibits Improved Pharmacokinetic Profile in Rats Compared to the Micronized Form: Benefits of Thin Film Freezing
Chaeho Moon, Sawittree Sahakijpijarn, Esther Y. Maier, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 2, pp. 564-580
Closed Access | Times Cited: 2

Impact of Aluminum Oxide Nanocoating on Drug Release from Amorphous Solid Dispersion Particles
Dana E. Moseson, Emily G. Benson, Ziyi Cao, et al.
Molecular Pharmaceutics (2022) Vol. 20, Iss. 1, pp. 593-605
Closed Access | Times Cited: 9

Evaluating Spray Drying and Co-Precipitation as Manufacturing Processes for Amorphous Solid Dispersions of a Low Tg API
Marina A. Solomos, Ashish Punia, Sugandha Saboo, et al.
Journal of Pharmaceutical Sciences (2023) Vol. 112, Iss. 8, pp. 2087-2096
Open Access | Times Cited: 5

A Commentary on Co-Processed API as a Promising Approach to Improve Sustainability for the Pharmaceutical Industry
Luke Schenck, Bailey Risteen, Lindsay Michelle Johnson, et al.
Journal of Pharmaceutical Sciences (2023) Vol. 113, Iss. 2, pp. 306-313
Open Access | Times Cited: 5

High-Drug-Loading Amorphous Solid Dispersions via In Situ Thermal Cross-Linking: Unraveling the Mechanisms of Stabilization
Afroditi Kapourani, Eleftherios G. Andriotis, Konstantina Chachlioutaki, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 12, pp. 4393-4414
Closed Access | Times Cited: 11

Dissolution Behavior of Weakly Basic Pharmaceuticals from Amorphous Dispersions Stabilized by a Poly(dimethylaminoethyl Methacrylate) Copolymer
Derek S. Frank, Prateek Prasad, Luca Iuzzolino, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 9, pp. 3304-3313
Closed Access | Times Cited: 8

Evaluating PAA/PVA thermal crosslinking process during the preparation of in-situ high-drug loading amorphous solid dispersions
Afroditi Kapourani, Konstantina Chachlioutaki, Eleftherios G. Andriotis, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 79, pp. 104030-104030
Closed Access | Times Cited: 8

Development of posaconazole nanocrystalline solid dispersion: preparation, characterization and in vivo evaluation
Ranga Goud Rayapolu, Balvant Yadav, Shashank Apte, et al.
Pharmaceutical Development and Technology (2024) Vol. 29, Iss. 5, pp. 530-540
Closed Access | Times Cited: 1

Posaconazole-hemp seed oil loaded nanomicelles for invasive fungal disease
Anjali Rathee, Pavitra Solanki, Nasr A. Emad, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets
Deanna M. Mudie, Aaron M. Stewart, Jesus A. Rosales, et al.
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1257-1257
Open Access | Times Cited: 8

Optimization of Spray-Drying Parameters for Formulation Development at Preclinical Scale
Marika Nespi, Robert J. Kuhn, Chun‐Wan Yen, et al.
AAPS PharmSciTech (2021) Vol. 23, Iss. 1
Closed Access | Times Cited: 8

Posaconazole Loading and Release Behavior in Surface-Modified Mesoporous Silica Nanoparticular System
Hilal ERKAN, Ceren Emir, Cem Özel, et al.
Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi (2023) Vol. 16, Iss. 3, pp. 615-632
Open Access | Times Cited: 3

Amorphous Solid Dispersion Tablets Overcome Acalabrutinib pH Effect in Dogs
Deanna M. Mudie, Aaron M. Stewart, Jesus A. Rosales, et al.
Pharmaceutics (2021) Vol. 13, Iss. 4, pp. 557-557
Open Access | Times Cited: 7

An Enabling Formulation of a Weakly Basic Compound Guided by Physiologically Based Biopharmaceutics Modeling (PBBM)
Fady Ibrahim
Journal of Pharmaceutical Sciences (2022) Vol. 111, Iss. 9, pp. 2490-2495
Closed Access | Times Cited: 4

Page 1 - Next Page

Scroll to top